KuangChi Science Limited provided consolidated earning guidance for year ended 31 December 2023. For the year ended 31 December 2023, the Group expects that it may record a significant decrease in net loss for the year ended 31 December 2023 (?FY2023?) with a net loss ranging from approximately HKD 6,000,000 to HKD 8,000,000 for FY2023 as compared to a net loss of approximately HKD 67,912,000 for the year ended 31 December 2022 (?FY2022?). The expected decrease in the unaudited net loss of the Group is primarily attributable to: During the year, the Group disposed of its equity in Irisity AB, an overseas listed company, and recognized a loss on changes in fair value of approximately HKD 600,000 (FY2022: a loss on changes in fair value of approximately HKD 19,500,000); During FY2023, the Group improved its marketing strategy and further reduced its operating expenses through effective control, with a significant decrease in selling and marketing expenses of approximately HKD 19,700,000; and During FY2023, the Group continuously enhanced its internal control, strictly cut costs and increased efficiency, resulting in a significant decrease in administrative expenses of approximately HKD 10,000,000.
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
0.64 HKD | +1.59% | -7.25% | -37.25% |
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-37.25% | 51.28M | |
-12.48% | 191B | |
+1.20% | 166B | |
+6.20% | 159B | |
+9.04% | 103B | |
+35.29% | 84.49B | |
+11.96% | 82.27B | |
-5.50% | 71.3B | |
-17.92% | 54.34B | |
-8.68% | 43.63B |
- Stock Market
- Equities
- 439 Stock
- News KuangChi Science Limited
- KuangChi Science Limited Provides Consolidated Earning Guidance for Year Ended 31 December 2023